(Nikki Harper) As psychedelic research continues to come of age, following decades of shunning, evidence is mounting that psychedelic drugs can have positive therapeutic effects. As we have previously reported here on Wake Up World, psilocybin (magic mushrooms) and MDMA (ecstasy) have both recently been granted Breakthrough Status by the FDA, a designation given to drugs with clinically significant and potentially far reaching benefits. Psilocybin is heading towards phase 3 human trials as a treatment for major depressive disorder, while MDMA is close to approval as a PTSD treatment.